Stem One Biologicals specializes in the collection, storage and preservation of umbilical blood stem cells.
It appears that the Bennnett, Coleman & Co wants to extend the clout of its private treaties' divison over everything - from online cos, to theatre chains to healthcare now.
Bennnett, Coleman & Co, the publishers of newspaper brands like The Times of India and The Economic Times has picked up minority stake in Stem One Biologicals, an autologous cord blood bank.
Promoted by the Purandare family, Stem One specializes in the collection, storage and preservation of umbilical blood stem cells, which can be used for the treatment of cosmetology related ailments and diseases like cancer, thalassemia, Parkinson's and Cardiac related problems.
Stem one is Maharashtra's first cord blood bank with its network expanding beyond cities in Gujarat and Madhya Pradesh. It is also into areas of stem cell research.
BCCL, through its private treaties division, an equity trading mechanism for ad and branding support in its paper(s), has lately acquired stakes in Pyramid Saimira Theatre, Royal Hygeine Care Pvt. Ltd., SMC Group, House of Laptops (India) Pvt.Ltd., First Altus Resources & Networks Pvt.Ltd.(Taxshax.com), Culture Holiday Pvt. Ltd.(TravelChaCha.com), CyberMedia Careers, and Naaptol Online Shopping Pvt. Ltd. among other firms.
-- Copyright 2008 VCCircle.com. All rights reserved.
This content/article is provided by Mosaic Media Ventures Private Limited and not by Reuters. All rights, including copyright, in this content/article provided by VCCircle.com are owned or controlled by Mosaic Media Ventures Private Limited. The content may not be copied, broadcast, downloaded and stored (in any medium), transmitted, adapted or changed in any way whatsoever without the prior written permission of Mosaic Media Ventures Private Limited.
Trending On Reuters
The Reserve Bank of India (RBI) kept its key lending rate unchanged on Tuesday, leaving the door open for more easing but making that dependent on meeting a challenging inflation target for 2017. Full Article